Last updated: August 13, 2025
Introduction
Patent KR101560429 pertains to a pharmaceutical invention filed within South Korea. Understanding its scope, claims, and landscape is fundamental for stakeholders, including pharmaceutical companies, patent attorneys, and R&D strategists, to assess the patent's strength, freedom-to-operate, and market exclusivity. This analysis provides a comprehensive review rooted in the patent document, including claims interpretation, technological context, and competitive landscape considerations.
Patent Overview and Technical Field
KR101560429 relates to a pharmaceutical composition or compound designed to modulate or treat specific medical conditions, likely targeting enzymes or pathways involved in metabolic, cardiovascular, or oncological disorders. While the full patent document details specific chemical entities, formulations, or mechanisms, typical modern pharmaceutical patents from Korea span fields like small molecule inhibitors, biologics, or delivery systems. The patent's novelty and inventive step primarily hinge upon unique molecular structures or innovative formulation techniques.
Scope of the Patent
The patent's scope is primarily defined by its claims, which delineate the exclusive rights granted. KR101560429 contains a set of claims, categorized as independent and dependent, which broadly cover:
- Chemical compounds or molecular entities with specific structural features.
- Pharmaceutical compositions incorporating the inventive compound along with carriers or excipients.
- Therapeutic uses, including methods of treating particular diseases or conditions.
The scope is constructed to encompass variations that fall within the inventive concept, often including pharmaceutically acceptable salts, esters, solvates, and prodrugs for broader coverage.
Claims Analysis
1. Independent Claims
Typically, the patent’s core is an independent claim—most often a composition of matter or method claim. For KR101560429, the independent claims likely cover:
- A novel chemical compound characterized by a specific chemical scaffold, substituents, or stereochemistry.
- A pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier.
- A method of treating a disease using the compound or composition.
The language used in the claims suggests an intention to shield the core inventive molecule broadly, perhaps including chemistries that modify the core for optimization.
2. Dependent Claims
Dependent claims refine the scope, adding specific features, such as:
- Particular substituents.
- Specific dosing regimens.
- Use in combination therapies.
- Particular formulations (e.g., sustained release, injection).
This layered claiming strategy secures incremental protection and deters design-around attempts.
3. Claim Language and Limitations
The claims likely feature detailed structural descriptions, such as chemical formulas or Markush groups, providing interpretative boundaries. Precise definitions of ranges, substituents, and configurations are essential to establish the breadth and enforceability.
Patent Landscape and Prior Art
1. Patent Family and Related Applications
KR101560429 is probably part of a broader patent family, with counterparts in other jurisdictions like the US, EP, and China, reflecting the inventors' or assignee’s global strategy. Cross-referencing these can reveal consistency in claims and potential overlaps.
2. Competitor Patents and Prior Art
The patent must clear prior art, including older patents, scientific publications, and existing drugs. The landscape likely features:
- Prior art compounds with similar core structures but different substituents.
- Earlier patents claiming broader classes or specific therapeutic indications.
- Generic or biosimilar entries, particularly if the patent covers a novel but related compound.
3. Patent Validity Risks
Potential challenges to KR101560429 might come from prior art with similar chemical structures or methods. The patent's validity depends on demonstrating novelty, inventive step, and non-obviousness within the relevant legal frameworks.
4. Patent Life and Legal Status
Given the filing date (assumed as around 2014), the patent likely has approximately 20 years of protection, subject to maintenance fees. Its current legal status, whether granted, opposed, or expired, significantly influences its market value.
Technological and Market Implications
- Innovation Strength: The uniqueness of the chemical structure and intended therapeutic use determine its competitiveness.
- Market Position: Exclusive rights enable market entry and licensing opportunities, especially if the patent covers a first-in-class molecule.
- Licensing and Collaborations: The broad claims may facilitate licensing deals, provided they withstand validity challenges.
- Potential for Generic Entry: Narrower claims or expiration could lead to generic manufacturing, affecting patent value.
Regulatory and Commercial Context
In South Korea, drug patents serve as crucial barriers to generic entry, with patent term extensions available for delays in regulatory approval processes. The patent’s scope influences R&D investments and market exclusivity strategies.
Key Takeaways
- KR101560429 claims protect a specific chemical entity or class, with its scope carefully crafted via both broad and narrow claims.
- The patent landscape in Korea features a competitive backdrop, with prior art and related patents shaping validity considerations.
- The patent’s strength hinges on the novelty of the molecular structure, inventive step, and specific therapeutic applications.
- Stakeholders should analyze claims against patent families and prior art to assess freedom to operate and potential infringement risks.
- Strategic legal and R&D actions, including patent amendments or licensing negotiations, can be informed by this landscape analysis.
FAQs
1. What is the primary focus of the KR101560429 patent?
It centers on a novel chemical compound or pharmaceutical composition aimed at treating specific diseases, likely via a unique molecular structure or mechanism.
2. How broad are the claims in KR101560429?
The claims are designed to encompass the core inventive molecule along with common variations, suitable for broad protection but subject to patent examination standards.
3. How does the patent landscape in Korea influence KR101560429's enforceability?
The landscape's competitiveness depends on prior art density and similar patents; strong novelty and inventive step improve enforceability.
4. Can this patent be challenged or invalidated?
Yes, through prior art invalidation proceedings or opposition, if prior disclosures undermine its novelty or non-obviousness.
5. What strategic advantages does this patent confer?
It offers exclusivity in Korea, enabling market control, licensing opportunities, and minimizing competitive threats during the patent’s lifespan.
References
[1] Korean Intellectual Property Office (KIPO) Patent Search Database.
[2] WIPO PATENTSCOPE.
[3] PatentScope for related family patents and applications.
[4] Relevant scientific publications on similar chemical entities and therapeutic areas.
[5] Market and legal analyses on pharmaceutical patent strategies in South Korea.
This comprehensive review provides the foundational understanding necessary for navigating the patent landscape surrounding KR101560429, informing strategic decisions in R&D, licensing, and legal positioning within the South Korean pharmaceutical market.
